Dr. Gregg J. Silverman, Professor
New York University Langone Medical Centre Musculoskeletal Centre of Excellence Immunology / Antibody Engineering, Lupus and Autoimmune disease
Thursday, September 11, 2014 - 11:00am
CCBR Red Room
Invited Speaker Seminar
Abstract:
The composition of the early immune repertoire is biased with prominent expression of spontaneously arising B cell clones that produce IgM with recurrent and often autoreactive binding specificities. Amongst these naturally arising antibodies (NAbs) are IgM antibodies that specifically recognize damaged and senescent cells, often via oxidation-associated neo-determinants. These NAbs are present from birth and can be further boosted by apoptotic cell challenge. Recent studies have shown that IgM NAb to apoptotic cells can enhance phagocytic clearance, as well as suppress proinflammatory responses induced via Toll-like receptors, and block pathogenic IgG-immune complex (IC)-mediated inflammatory responses. Clinical surveys have suggested that anti-apoptotic cell (AC) IgM NAbs modulate disease activity in some patients with autoimmune disease. Taken together, the novel properties of this class of protective NAbs may directly blunt inflammatory responses through a primitive pathway for regulation of the innate immune system.
Host:
Dr. Sachdev Sidhu, The Donnelly Centre for Cellular + Biomolecular Research
Donnelly CCBR Seminar